Navigation Links
Thermage, Inc. Announces Initial Shipments of Cellulite Product
Date:3/12/2008

HAYWARD, Calif., March 12 /PRNewswire-FirstCall/ -- Thermage, Inc. (Nasdaq: THRM), a leader in non-invasive tissue tightening in the aesthetic industry, today announced it has begun initial shipments of its ThermaTip(TM) CL treatment tips for use in the Company's cellulite procedure. The procedure noticeably reduces the appearance of cellulite after just a single treatment. The treatment tip and procedure are the result of 21 months of clinical and technological development and use the FDA cleared ThermaCool(R) system for the temporary improvement in the appearance of cellulite.

"We began shipments of our ThermaTip CL treatment tip on track and within the timeframe we expected," said Stephen J. Fanning, Chairman of the Board, President and Chief Executive Officer at Thermage. "Cellulite offers a new market opportunity for our Company and we expect the new tip to provide a solid contribution to our revenue in 2008."

The ThermaTip CL and cellulite procedure by Thermage incorporate the Company's patented monopolar capacitive radiofrequency technology. The advanced deep heating ThermaTip CL rebuilds collagen connective tissues and improves blood flow to the tissue helping to smooth the appearance of the skin's surface.

About Thermage

Thermage's innovative technology provides a unique non-invasive procedure designed to tighten and contour skin, significantly expanding the non-invasive aesthetic applications physicians can offer to the rapidly growing "anti- aging" market. For more information about Thermage, call 1-510-259-7117 or log on to http://www.thermage.com.

This press release may contain forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 including the statement regarding revenue contribution of the cellulite treatment tip. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause Thermage's actual results to differ materially from the statements contained herein including the risk that the new tip does not achieve commercial acceptance or that such acceptance is delayed, among other risks. Further information on potential risk factors that could affect Thermage's business are detailed in the Company's Form 10-Q for the period ended September 30, 2007. Undue reliance should not be placed on forward-looking statements, which speaks only as of the date they are made. Thermage undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.

Results vary from subtle to dramatic. Generally improvements may be immediately visible and continue to improve for up to six months. Results are long lasting and depend on your skin condition and the aging process.


'/>"/>
SOURCE Thermage, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Thermage, Inc. Announces Fourth Quarter 2007 Results Release Date and Conference Call
2. Thermage, Inc. Appoints John F. Glenn as Chief Financial Officer
3. Thermage, Inc. Announces Distribution Agreement With Eclipse Medical, Ltd.
4. Thermage, Inc. to Present at the Maxim Group Growth Conference
5. Bradmer announces 2007 fourth quarter and fiscal year operational and financial results
6. NHP Announces Management Promotions
7. WellPoint Announces Appearances at Upcoming Conferences
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at Lehman Brothers Global Healthcare Conference
9. St. Alcuin Montessori School Announces $5 Million Capital Campaign Gift
10. Hooper Holmes Announces Fourth Quarter Earnings Release Date and Conference Call Information
11. Ambulatory Services of America, Inc. Announces Joint Venture with Southern Ocean County Radiation Oncology, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2016)... North Carolina (PRWEB) , ... May 29, 2016 , ... ... Now, via Amazon.com, their new KlipPro KP-240L clipper is available to the public. This ... which is substantially wider than the average clipper. , Everything about this product ...
(Date:5/28/2016)... ... May 28, 2016 , ... "Color Grading media can be time consuming ... onto their media," said Christina Austin - CEO of Pixel Film Studios. , ... easily add stylish color grades to their footage. A LUT is a Lookup Table ...
(Date:5/28/2016)... ... May 28, 2016 , ... In a part of the city where’s it’s easy ... farm-to-table Kelowna restaurants is hoping to attract diners with a taste for real ... officially opened the doors to Cornerstone Grill, an urban casual restaurant focusing on dishes ...
(Date:5/27/2016)... ... May 27, 2016 , ... Two director-level employees of ... Tribute to Women and Industry (TWIN) 2016 honorees. The award recognizes businesswomen who ... this year, Geri Boone, Director of the MLTSS (Managed Long-Term Services and Supports) Program ...
(Date:5/27/2016)... ... May 27, 2016 , ... With over 60 percent of acute stroke survivors ... sustainable product to aid in the rehabilitation process has steadily increased. Ekso Bionics had ... with hemiplegia due to stroke. , Ekso Bionics has now received clearance from the ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Kitov Pharmaceuticals ... late-stage drug development, today announced the completion of ... batches required for registration of KIT-302 with the ... Kitov,s announcement in December 2015, that ... primary efficacy endpoint. "We are fortunate ...
(Date:5/26/2016)... May 26, 2016 A key ... is the emergence of new treatments. Cardax, a development ... osteoarthritis treatment. The therapy is expected to fulfil large ... UK is conducting studies to develop new treatments for ... the genes involved in osteoarthritis are being investigated, and ...
(Date:5/25/2016)... FDA 510(k) clearance covers Confocal Miniprobes ... and surgical applications Mauna Kea Technologies ... multidisciplinary confocal laser endomicroscopy (CLE) platform, today announced ... the 12 th 510(k) clearance from United ... FDA clearance covers Confocal Miniprobes indicated for use ...
Breaking Medicine Technology: